Report finds most cannabis products still lack key label details
A ConsumerAffairs report says most cannabis products on shelves still omit important label information, putting a fresh spotlight on state labeling compliance.

Collection of vintage apothecary bottles showcasing historical pharmaceutical storage.
A report says label gaps persist across most products
ConsumerAffairs reported Nov. 20, 2026 that most cannabis products on the market still lack important label information.
What CannIntel has in hand is the headline and publication details of that report, not its underlying dataset. We haven't independently reviewed the sample size, the jurisdictions covered, or which specific label elements were found missing. Operators should read the original report before drawing conclusions about their own exposure, since the finding could be market-wide or far narrower.
Still, the direction of the finding fits what compliance counsel have long described. Labeling is where licensed operators most often fall short. The requirements are granular, and they differ by state.
What label information is typically required
State cannabis labeling codes generally require a defined set of disclosures, and omissions can constitute violations regardless of product quality.
Requirements vary, but regulated markets commonly mandate some combination of the following. On a strict reading, each is a separate compliance element:
- Cannabinoid potency, including THC and CBD content per serving and per package
- Batch or lot identifiers tied to certificate-of-analysis testing
- Government health warnings and universal symbols
- Net weight, ingredient lists, and allergen statements for edibles
- Licensee name and license number
Each state writes its own list. A product that's compliant in one market can be deficient in the next, and multi-state operators carry that burden across every SKU they sell.
Why a label defect is a licensing problem, not a design problem
Under most state cannabis statutes, mislabeling can trigger product holds, recalls, fines, or license action.
Regulators treat the label as the consumer's primary safety interface. On a strict reading of most state codes, a missing warning or inaccurate potency figure is a violation on its face. Intent rarely matters.
That makes the ConsumerAffairs finding more than a consumer-advocacy talking point. If the pattern holds, it implies a large inventory of technically noncompliant product sitting in licensed channels, and enforcement agencies, including state cannabis control boards and departments of revenue, have discretion over when and how to act on it.
The tax and accounting angle operators overlook
Label failures carry downstream financial costs that fall outside the 280E conversation but hit the same margins.
Cannabis operators already pay federal tax under IRC §280E, which disallows ordinary business deductions for trafficking in Schedule I or II substances. Recall costs, destroyed inventory, and relabeling labor all compress gross margin in a regime where only cost of goods sold is generally deductible.
Whether a given relabeling or destruction expense qualifies as inventory cost or a nondeductible operating expense is a fact-specific question for tax advisers. Operators shouldn't assume favorable treatment. State excise and sales-tax filings can also be affected if products are pulled from sale after tax was remitted, depending on each state's revenue code.
The takeaway is simple. A labeling error is cheapest to fix before the product ships.
What operators and retailers should do now
The practical response is an internal label audit against current state rules, run SKU by SKU.
Retailers share exposure with brands in many jurisdictions, since licensees can be cited for selling noncompliant product. A receiving-dock check against a state-specific checklist is a low-cost control. Brands should confirm that label templates were updated after each rule change and that potency figures match the latest lab results.
Compliance teams should also document their review. In an enforcement action, a dated audit trail can matter as much as the fix itself.
For full background on this story, see the CannIntel topic hub on cannabis product labeling compliance. Operators in California should check Department of Cannabis Control (DCC) packaging rules, and those in Colorado, Oregon, and Ohio should confirm their own regulators' current requirements, since each state maintains separate labeling and testing regimes.
Watch for the original report's methodology. It will determine whether this is a market-wide indictment or a narrower finding.
Frequently asked questions
What did the ConsumerAffairs report find about cannabis labels?
ConsumerAffairs reported on Nov. 20, 2026 that most cannabis products are still missing important label information. CannIntel has not reviewed the underlying data, so the sample, jurisdictions, and specific omitted elements should be confirmed in the original report.
What information must cannabis labels include?
It depends on the state. Common requirements include THC and CBD potency, batch identifiers tied to lab testing, government health warnings, net weight, ingredients and allergens for edibles, and the licensee's name and license number.
Can a labeling error cost a cannabis business its license?
It can. Under most state cannabis statutes, mislabeling may result in product holds, recalls, fines, or license action. Outcomes depend on the state regulator, the severity of the violation, and the operator's compliance history.
How does labeling compliance connect to Section 280E?
IRC §280E disallows ordinary business deductions for cannabis businesses, so recall, destruction, and relabeling costs can squeeze margins. Whether a specific cost qualifies as deductible cost of goods sold is fact-specific and should be reviewed with a tax adviser.
Sources
The cannabis newsletter you forward to your team.
Federal policy, market data, grower alerts, and the one story that matters today. Sent every weekday at 7am. Free.
No spam. Unsubscribe with one click. 21+ only.
Related from Laws

Congressional Researchers Cite 280E as Model for Taxing AI Data Centers
Congressional researchers are pointing to the cannabis industry's 280E deduction ban as a template for taxing AI data centers, per a Marijuana Herald report.

Federal hemp ban puts pet CBD market and animal safety at risk
Hemp-derived CBD products for pets face disappearance under the federal hemp ban, and neither regulators nor lawmakers have a plan for what replaces them.

Federal hemp ban puts pet CBD products in regulatory limbo
Hemp-derived CBD products for pets face disappearance under the federal hemp ban, raising a safety and market question few regulators have addressed.
More from the newsroom

Terrabis Opens Drive-Thru Dispensary in Mundelein, Illinois
Terrabis added a drive-thru lane to its Mundelein, Illinois dispensary, a convenience play that tests how far format can stand in for price in a crowded Chicago-area market.

Operator Bulletin: California Checkout Rules, Metrc, Hemp Insurance
California retailers face new checkout duties, Minnesota operators get Metrc deadlines, a cannabis contract ruling stands, and USDA updates hemp crop insurance.

NC cannabis bills face pending deadlines, renewed focus
A Winston-Salem Journal report says North Carolina lawmakers are turning back to cannabis legislation as deadlines approach; the signal supplies no bill numbers or vote dates.